Document resource
The 2026 American Diabetes Association (ADA) Standards of Care position diabetes technologies as integral components of routine diabetes management rather than optional adjuncts, reflecting a shift towards broader eligibility, earlier initiation and sustained access across care settings. 1 Across device categories, the guidance emphasises individualised, patient-centred selection, with technology choice informed by personal circumstances, preferences and capabilities and caregiver involvement where relevant.1